SEP 24, 2014 05:00 AM PDT

Algorithmic Drug Design (Prerecorded)

Speakers
  • Chair of Medicinal Informatics and Professor of Translational Biology, University of Dundee
    Biography
      Andrew attended the University of Manchester on a British Steel Scholarship, graduating with a First Class Honours in Chemistry. Following a spell in the steel industry, Andrew undertook a doctorate in molecular biophysics under at the University of Oxford under the supervision of Prof David Stuart FRS. Directly from Oxford he joined Pfizer in 1998, where he established various new functions for the company including the Target Analysis Group, Indications Discovery and Knowledge Discovery. He has won several awards including the Royal Society of Chemistry's Capps Green Zomaya medal (2008); Corwin Hansch Award (2007); Pfizer Team Achievement Award (2004); Pfizer Achievement Award (2002); Pfizer Leadership Award (2002). Andrew's papers include the highest cited paper published in the past 5 years by Nature Chemical Biology and the second highest cited paper ever published by Nature Reviews Drug Discovery.

    Abstract:
    Since leaving Pfizer to go back to academia in 2007, Andrew Hopkins (University of Dundee, UK) has been a leading researcher in the search for new informatics and computational methods to improve the design of effective drug candidates against G-protein coupled receptors and other prominent drug classes. In this presentation, Hopkins reviews his groups latest progress using Bayesian approaches for Algorithmic Drug Design, which show immense promise for the identification of new classes of small molecule drug compounds.

    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    SEP 12, 2017 08:00 AM PDT
    SEP 12, 2017 08:00 AM PDT
    DATE: September 12, 2017TIME: 8:00am PT, 11:00am ETEvery year, millions of dollars are wasted on poorly characterized and performing antibodies.  Key researchers in the antibody co...
    NOV 15, 2018 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 15, 2018 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE:  November 15, 2018TIME:  10:00am PT, 1:00pm ET Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the ana...
    NOV 14, 2017 09:00 AM PST
    C.E. CREDITS
    NOV 14, 2017 09:00 AM PST
    DATE: November 14, 2017TIME: 09:00am PST, 12:00pm ESTThe CRISPR-Cas9 system has been adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and av...
    Loading Comments...